One of the common aesthetic concerns that affect men and women, a double chin is usually occurs due to factors such as aging, genetics and weight gain. KYBELLA in NYC is an innovative treatment for this aesthetic concern. KYBELLA is the first and only double-chin injectable treatment. This FDA-approved treatment can address this unwanted fat under the chin or submental fat that causes a double chin and turkey neck – that too, without surgery or downtime. However, if you are considering the KYBELLA injectable treatment, there are certain things that you need to discuss with your plastic surgeon.
Before the treatment, your plastic surgeon will examine the area under and around your chin to determine if KYBELLA double chin treatment is right for you. Not every person is an ideal candidate for the procedure such as person with an infection in the treatment area is not a good candidate for the treatment.
At the outset it’s important to that you get proper information regarding KYBELLA and what it involves. Before receiving KYBELLA double chin treatment, tell your plastic surgeon about your all your medical conditions, as well as if you:
- Have had or plan to have surgery on your face, neck, or chin
- Have had cosmetic treatments on your face, neck, or chin
- Have had or have medical conditions in or near the neck area
- Have had or have trouble swallowing
- Have bleeding problems
- Are pregnant or plan to become pregnant
- Are breastfeeding or plan to breastfeed
- Are taking any medications, especially blood thinners
Inform your surgeon about all the medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements and importantly, if you take a medicine that prevents the clotting of your blood (an antiplatelet or anticoagulant medication).
After determining the candidature, your specialist will tailor your treatment to the amount of fat under the chin and your aesthetic goals. Kybella NYC involves administering a synthetic deoxycholic acid injection into the treatment site. A naturally occurring molecule in the body, deoxycholic acid helps in breaking down and absorbing dietary fat. When injected into the fat beneath the chin, KYBELLA destroys fat cells, resulting in a visible reduction in the fullness under the chin. Once destroyed, the cells cannot store or accumulate fat. Quicker and easier than chin liposuction, this in-office procedure typically takes 15-20 minutes, with injections taking only 5 minutes. Each KYBELLA treatment session is given at least 1 month apart, and you should not receive more than 6 treatments. In clinical studies, 59% of patients received 6 treatments. Re-treatment is not necessary once you reach your desired goal.
You can expect to see a noticeable change in your chin profile in two to four treatments and optimal outcomes in six sessions. Since everyone’s chin profile is different, the number of treatments required varies from patient to patient.
Though the procedure is nonsurgical, after this treatment, some bruising and swelling is expected, but won’t last for long. Swelling usually lasts for just two days but can last for up to three weeks or more in people with larger volumes of treated fat and higher doses. As older patients tend to have more skin laxity, swelling may take longer to resolve than in those with tighter skin. Be sure to inform your plastic surgeon if you develop open sores or drainage from the treatment area, an uneven smile, facial muscle weakness, difficulty swallowing or injection site problems such as bruising, hair loss, open sores (ulcers), and damage and tissue cell-death (necrosis) around the injection site.
Today, more and more men and women are choosing Kybella in NYC to reduce chin fat and achieve a sculpted jawline without surgery. To benefit from optimal outcomes, it is important that you choose a plastic surgeon who is experienced and skilled in administering this double-chin injectable treatment. Treatment at a reliable accredited NYC plastic surgery practice will ensure compliance with the highest standards of care and patient safety.